Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Rubin

Showing results (41-50 of 85) with videos related to

Pageof 9
Sort By:
British Journal of Psychology (London, England : 1953)|March 9, 2023
Sleep as a mediator of the relationship between social class and health in higher education studentsRomany McGuffog, Mark Rubin, Mark Boyes, et al.
Journal of Agricultural and Food Chemistry|September 21, 2011
Identification and synthesis of new volatile molecules found in extracts obtained from distinct parts of cooked chickenEstelle Delort, Alain Velluz, Eric Frérot, et al.
The British Journal of Social Psychology|July 4, 2026
Rethinking social media metrics: Daily interaction valence and well-being in university studentsAseel Sahib, Stephanie L Hardacre, Olivia Evans, et al.
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancerJohanna C Bendell, Anthony Meluch, James Peyton, et al.
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortiumJohn D Hainsworth, David R Spigel, F Anthony Greco, et al.
Clinical Breast Cancer|June 14, 2011
Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research ConsortiumDenise A Yardley, Howard A Burris, Bobby L Clark, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancerRogerio Lilenbaum, Mark Rubin, Joyce Samuel, et al.
BJU International|September 8, 2007
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancerEric J Small, Joseph Fontana, Nizar Tannir, et al.
Prostate Cancer and Prostatic Diseases|February 11, 2021
Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancerAndrew J Armstrong, Xiaotong Li, Matthew Tucker, et al.
Personality & Social Psychology Bulletin|September 4, 2012
The contact caveat: negative contact predicts increased prejudice more than positive contact predicts reduced prejudiceFiona Kate Barlow, Stefania Paolini, Anne Pedersen, et al.
Pageof 9

Showing results (41-50 of 85) with videos related to

Sort By:
Pageof 9
British Journal of Psychology (London, England : 1953)|March 9, 2023
Sleep as a mediator of the relationship between social class and health in higher education studentsRomany McGuffog, Mark Rubin, Mark Boyes, et al.
Journal of Agricultural and Food Chemistry|September 21, 2011
Identification and synthesis of new volatile molecules found in extracts obtained from distinct parts of cooked chickenEstelle Delort, Alain Velluz, Eric Frérot, et al.
The British Journal of Social Psychology|July 4, 2026
Rethinking social media metrics: Daily interaction valence and well-being in university studentsAseel Sahib, Stephanie L Hardacre, Olivia Evans, et al.
Clinical Advances in Hematology & Oncology : H&O|August 17, 2012
A phase II trial of preoperative concurrent chemotherapy/radiation therapy plus bevacizumab/erlotinib in the treatment of localized esophageal cancerJohanna C Bendell, Anthony Meluch, James Peyton, et al.
Cancer Journal (Sudbury, Mass.)|September 29, 2011
Combined modality treatment with chemotherapy, radiation therapy, bevacizumab, and erlotinib in patients with locally advanced squamous carcinoma of the head and neck: a phase II trial of the Sarah Cannon oncology research consortiumJohn D Hainsworth, David R Spigel, F Anthony Greco, et al.
Clinical Breast Cancer|June 14, 2011
Hormonal therapy plus bevacizumab in postmenopausal patients who have hormone receptor-positive metastatic breast cancer: a phase II Trial of the Sarah Cannon Oncology Research ConsortiumDenise A Yardley, Howard A Burris, Bobby L Clark, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 6, 2007
A randomized phase II trial of two schedules of docetaxel in elderly or poor performance status patients with advanced non-small cell lung cancerRogerio Lilenbaum, Mark Rubin, Joyce Samuel, et al.
BJU International|September 8, 2007
A phase II trial of gefitinib in patients with non-metastatic hormone-refractory prostate cancerEric J Small, Joseph Fontana, Nizar Tannir, et al.
Prostate Cancer and Prostatic Diseases|February 11, 2021
Molecular medicine tumor board: whole-genome sequencing to inform on personalized medicine for a man with advanced prostate cancerAndrew J Armstrong, Xiaotong Li, Matthew Tucker, et al.
Personality & Social Psychology Bulletin|September 4, 2012
The contact caveat: negative contact predicts increased prejudice more than positive contact predicts reduced prejudiceFiona Kate Barlow, Stefania Paolini, Anne Pedersen, et al.
Pageof 9